2023Greater Bay Area Biotech Innovation Forum | Review, Summary

As the frontier city of China’s reform and opening up and one of the core cities of the Guangdong-Hong Kong-Macao Greater Bay Area, Shenzhen has always been committed to high-quality development, especially in the industries of high-end medical devices, synthetic biology, cells and genes. Shenzhen also places great emphasis on academic exploration and achievement transformation. In the fields of biocomputing and artificial intelligence, cutting-edge biotechnology, molecular diagnostic technology, and cellular science and technology, Shenzhen has always been at the forefront of the trend, and continues to promote scientific and technological innovation and industrial upgrading. By continuously strengthening the cooperation between industry, academia and research, Shenzhen has established a number of high-level scientific research institutions and innovation platforms, and attracted many outstanding scientists and innovative talents, providing strong support for the development of the biomedical industry.

In order to promote academic exchanges and transformation of scientific and technological achievements in the field of biotechnology in the Greater Bay Area, EarlyScreening.com, together with HUACHENYANG TECH, PANDO BIO
PANDO Genetic Research Institute, PANDO Health Management and other companies, jointly planned the “Greater Bay Area Biotech Innovation Forum”. The forum aims to build a communication platform for management, industry leaders, industry elites, industry chain, experts and scholars to participate, share ideas, collision of wisdom, open and inclusive attitude to help industrial development, creating unlimited possibilities for the future.

Highlights of the Forum

• 01 Academic Exchange
  A number of experts on-site report on the academic frontier
• 02 Rich topics
  Computational science, AI, single-cell sequencing, hereditary tumor prevention and control
• 03 Nobel Prize Academician on-site
  You have the opportunity to communicate with Nobel Prize winners, academicians and academic experts, and get professional advice.

Guests of Honor

• Director, Key Laboratory of Single Cell, Southern Medical University

• 2013 Nobel Laureate in Chemistry
• Member of the U.S. National Academy of Sciences

• Fellow, American Academy of Medical and Biological Engineering
• Founding Dean, School of Computer Science and Control Engineering, Shenzhen Polytechnic University, China

• Zhujiang Hospital, Southern Medical University
• Former Director of Molecular Pathology, MD Anderson Cancer Center, USA

• Director of Technology Transformation, Hong Kong Quantum Artificial Intelligence Experiment
• Honorary Senior Research Associate, The University of Hong Kong
• Fellow of the Royal Society of Medicine

Chairman of Huachenyang (Shenzhen) Tech Co., Ltd.

Chairman of Shenzhen Pandobio Tech Co., Ltd.

Content of the Forum

01 Guest Speaker

Lou Yanfeng, Deputy Director of Shenzhen Science and Technology Innovation Commission, said that Shenzhen has been actively responding to the national policy call to increase investment and support in biotechnology, encouraging all kinds of innovative entities to participate in research and innovation in biomedicine, bioinformatics, biomanufacturing and other fields, and to promote industrial upgrading and technological breakthroughs. Therefore, biotechnology innovation is undoubtedly an engine for the future development of Shenzhen and the Guangdong-Hong Kong-Macao Greater Bay Area. He also said that the Shenzhen Science and Technology Innovation Commission will continue to pay attention to, support and encourage innovation and cooperation, provide more opportunities and resources for biotechnology innovation, and work together to promote the biotechnology industry in the Guangdong-Hong Kong-Macao Greater Bay Area towards a more prosperous future.

Afterwards, Mr. Gong Zhanhua, Chairman of Pando Bio, the organizer of the conference, delivered a speech at the conference. He said that Shenzhen is the city of innovation, the land of reform, and the core city of Guangdong-Hong Kong-Macao Greater Bay Area. Since its establishment in Shenzhen in 2008, Huachenyang Tech has grown with the development of this city. Shenzhen has always been at the forefront of the country’s reform and opening up, and innovation and practical work are important labels of this city. He is deeply grateful that Shenzhen has made a number of enterprises like Huachenyang Tech, and Huachenyang’s own struggle has also witnessed the development of the city. He hopes that this high-quality forum will open a new chapter and make a new plan for the future development of Huachenyang Tech, and looks forward to working hand in hand with all colleagues for win-win cooperation in the future.

02 Personal Speech

Prof. Xinghua Pan: Innovations in Single-Cell Sequencing Technology for Disease Research and Precision Prevention and Treatment

Prof. Lu Guohui: New Advances in Prevention and Control of Hereditary Tumors

Prof. Yi Pan: Artificial Intelligence Enabling Biomedicine: Drug Screening and Drug Generation

Yuan Huang, MD: Artificial Intelligence Enabled Longevity Medicine: Epigenetic Principles and Target Screening

Prof. Arieh Warshel：Modeling the Action of Complex Biological Systems on a Molecular Level

03 Academic Discussion

Experts gathered together to have an in-depth academic discussion on the current hot topics. Their brilliant speeches and insights not only brought us new ideas, but also injected new vitality into the research and development of the field.

04 Signing Ceremony

During the consulting session, Mr. Gong Zhanhua, Chairman of Pando Bio (Huachenyang), appointed Prof. Arieh Warshel, 2013 Nobel Laureate in Chemistry, Prof. Lu Guohui, former Director of Molecular Diseases of MD Anderson Cancer Center, Zhujiang Hospital of Southern Medical University (SMU), and Prof. Pan Xinghua, Director of the Key Laboratory of Macroblasts of SMU, as scientific advisors of Pando Bio. Professor Pan Xinghua, Director of the Key Laboratory of Large Cells of Southern Medical University, were appointed as scientific advisors of Pando Bio.

In the strategic signing session, Mr. Zhanhua Gong, Chairman of Pando Bio (Huachenyang), signed the strategic cooperation with Prof. Xinghua Pan, Director of Medical Research Institute of SequMed Biotech Inc, Mr. Yudong Xia, General Manager of MethylGene, and Mr. Zhanquan Chen, CEO of Zao Dx, respectively.

05 Common Vision

Together, we are committed to promoting the development of the health management industry and providing people with better health services. We believe that with joint efforts, the health industry will usher in a better tomorrow.